UK-US Trade Deal Could Divert £45 Billion From NHS Care by 2036

A BMJ analysis warns that the UK-US pharmaceuticals deal could divert up to £45 billion from other NHS services by 2036, with knock-on costs landing squarely on adult social care. For commissioners already stretched thin, the real question is not whether the deal delivers cheaper medicines, but what it quietly takes away.
Continue reading UK-US Trade Deal Could Divert £45 Billion From NHS Care by 2036

Doctolib And Medicus Target UK GP Modernisation With £100m Investment

Doctolib is entering the UK market through the acquisition of NHS software company Medicus, backed by a planned £100 million investment in British primary care technology. The deal could reshape the GP software market while accelerating the use of AI and digital tools across community healthcare. Continue reading Doctolib And Medicus Target UK GP Modernisation With £100m Investment

Liverpool Testbed Puts AI And Immersive Tech At Centre Of Social Care Reform

A visit from the Casey Commission to Liverpool has highlighted how emerging technologies could play a growing role in reshaping adult social care. From AI driven insights to augmented reality, the region is positioning itself as a live testing ground for the future of care in the UK. Continue reading Liverpool Testbed Puts AI And Immersive Tech At Centre Of Social Care Reform

TechTransforming Parkinson’s Disease Treatment in 2026

Every twenty minutes, someone in the UK is diagnosed with Parkinson’s disease, yet treatment progress has historically moved slowly, built on decades-old drugs and incremental surgical advances. That is now changing, with major UK-led trials and emerging technologies signalling a rapid shift in how the condition may be detected, monitored, and treated. Continue reading TechTransforming Parkinson’s Disease Treatment in 2026